News

Find updates on the work of our researchers here, as well as news about recent advances in Alzheimer's science, funding and awareness.

Eldercare Provider is Auspicious Neighbor

In May, Cure Alzheimer’s Fund moved its Massachusetts headquarters to a new location in Wellesley Hills. Our neighbor, CareScout, shares a passion for ending Alzheimer’s disease, and it has been a pleasure to get to know them and their business.

 

Scaling Heights to Cure Alzheimer's

Mountaineer to Raise Awarness, Research Funding for Alzheimer's on Road Back to Everest

Boston - Embarking on a yearlong challenge that he hopes will end at the top of Mt. Everest, mountain climber Alan Arnette will take on a greater challenge along his journey, raising money for research and public awareness of Alzheimer’s disease.

Cure Alzheimer's Fund Welcomes Two Prominent Scientists

Caleb Finch, Ph.D. joins Scientific Advisory Board

Dr. Finch is a professor of gerontology and biological sciences with adjunct appointments in the Department of Psychology, the Department of Physiology and the Department of Neurology at the University of Southern California. Dr. Finch’s major research interest is the study of genomic controls of mammalian development and aging.

Memories are Everything: Raising $100,000 for Alzheimer's Research

The Road Back to Mt. Everest

Photo of Alan Arnette
Mountain climber Alan Arnette

"Standing at 27,200’ on the icy slopes of Mount Everest in 2003, I lectured myself between gags that this was it. No more. I was too old and my body was just not fit for high altitude mountaineering. After all, it was only 363 days earlier that I had stood on this exact same spot suffering convulsions and made my own decision to return to the South Col before it was too late. Those experiences have come to shape my life in ways I never imagined. They are memories I hope to never forget. And now I’m going back."

Thus writes mountain climber Alan Arnette. Alan, recently retired, is embarking on a year-long challenge to climb Mt. Everest and raise $100,000 for Cure Alzheimer's Fund.

Coalition of Alzheimer's Organizations Announces New "Genius Grant" for Younger Researchers

In an effort to support the next generation of leading Alzheimer's researchers, the Cure Alzheimer's Fund has joined with the Alzheimer's Association and the Lou Ruvo Brain Institute to create and fund a new "genius grant" for young Alzheimer's researchers.

New Research Linking Alzheimer's, Stroke Provides New Window on Cure, Treatment

The Cure Alzheimer's Fund released the following statement on new research linking Alzheimer's disease risk to stroke published in Neuron on June 7, 2007. “We applaud Dr. Rudolph Tanzi, Dr. Giuseppina Tesco and Massachusetts General Hospital on their new research showing how a stroke or major head injury increases the risk for Alzheimer's disease. “The research community has established that link for some time, but not fully understood what caused it and the mechanism by which a stroke or brain injury impacts the brain.

Coalition of Alzheimer's Organizations Announces New "Genius Grant" for Younger Researchers

In an effort to support the next generation of leading Alzheimer's researchers, the Cure Alzheimer's Fund has joined with the Alzheimer's Association and the Lou Ruvo Brain Institute to create and fund a new "genius grant" for young Alzheimer's researchers.

Congressman Ed Markey Praises Cure Alzheimer's Fund for Research Efforts

Cure Alzheimer’s Fund researcher, Dr. Rudy Tanzi, briefed Congress on the progress of the fast track effort to map genes for Alzheimer’s disease.

MetLife Foundation Award given to Cure Alzheimer's Researcher

Dr. David Holtzman, a member of Cure Alzheimer’s Fund Research Consortium, received the prestigious MetLife Foundation Award for Medical Research in Alzheimer’s Disease.

MassGeneral Honors Cure Alzheimer's Fund with the "Philanthropic Innovation and Investment" Award

Massachusetts General Hospital and the MassGeneral Institute for Neurodegenerative Disease (MIND) has honored Cure Alzheimer’s Fund for its leadership, entrepreneurial philanthropy and investment in research projects that have the highest probability of slowing, stopping or reversing Alzheimer’s disease.